Whitehawk Therapeutics Inc
USD4.18
-0.31 (-6.90%)
CEO
David J. Lennon
IPO Date
2017-08-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.46
Prev. Close
$4.49
Day Low
$4.12
Day High
$4.46
52W Low
$1.57
52W High
$5.50
Market Cap
$0.21B
Volume
0.21M
| 51,020 |
| $3.92 |
| 18 May 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | A-Award | Acquired | 38,265 | $3.92 |
| 18 May 2026 | Lennon David James | director, officer: CHIEF EXECUTIVE OFFICER | A-Award | Acquired | 51,021 | $3.92 |
| 18 May 2026 | Castelein Caley | director | A-Award | Acquired | 255,102 | $3.92 |
| 18 May 2026 | Castelein Caley | director | A-Award | Acquired | 2,072,756 | $0.00 |
| 14 May 2026 | Avoro Capital Advisors LLC | director, 10 percent owner, other: See Remarks | A-Award | Acquired | 6,377,714 | $0.00 |
| 17 Apr 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | S-Sale | Disposed | 77,000 | $3.86 |
| 17 Apr 2026 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | S-Sale | Disposed | 141,600 | $4.13 |
| 15 Apr 2026 | BALL BRYAN | See remarks | S-Sale | Disposed | 26,389 | $3.46 |